FOLH1 and prostate cancer: The issue of pathological upgrading following radical prostatectomy poses a significant challenge for urologists, and prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography(PET/CT) has gained increasing prominence as a preoperative assessment tool for patients with prostate cancer in recent years.